Blair William & CO Fulgent Genetics, Inc. Transaction History

Blair William & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$66.8 - $100.45 $174,014 - $261,672	-2,605 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$59.3 - $183.85 $154,476 - $478,929	2,605 New	2,605 $252,000
Q4 2017 Feb 14, 2018	SELL	$3.01 - $4.9 $76,237 - $124,107	-25,328 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$4.57 - $6.39 $115,748 - $161,845	25,328	25,328 $121,000

207

17.1M

2.36M

47.9K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $511M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.